TREM2 rare variant p.R47H is not associated with Parkinson's disease

Parkinsonism and Related Disorders

Volumn 23, Issue , 2016, Pages 109-111

  Mengel, David ^a   Thelen, Mathias ^b   Balzer Geldsetzer, Monika ^a   Söling, Charlotte ^a   Bach, Jan Philipp ^c   Schaeffer, Eva ^d   Herold, Christine ^e   Becker, Tim ^b,e   Liepelt, Inga ^d   Becker, Julian ^b   Riedel Heller, Steffi ^f   Scherer, Martin ^g   Jessen, Frank ^b,e,h   Maier, Wolfgang ^b,e   Dodel, Richard ^a   Ramirez, Alfredo ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^f UNIVERSITY OF LEIPZIG   (Germany)

^g UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^h UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Association; Dementia; Non motor symptoms; Parkinson's disease; TREM2

Indexed keywords

TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; TREM2 PROTEIN, HUMAN;

ALLELE; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; EXON; GENE; GENE FREQUENCY; GENE FUNCTION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; LETTER; MAJOR CLINICAL STUDY; PARKINSON DISEASE; PRIORITY JOURNAL; RISK FACTOR; TREM2 GENE; AGED; FEMALE; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; MALE; META ANALYSIS; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IMMUNOLOGIC;

EID: 84949267166     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2015.11.026     Document Type: Letter

References (4)

1. Rayaprolu S., Mullen B., Baker M., Lynch T., Finger E., Seeley W.W., Hatanpaa K.J., Lomen-Hoerth C., Kertesz A., Bigio E.H., Lippa C., Josephs K.A., Knopman D.S., White C.L., Caselli R., Mackenzie I.R., Miller B.L., Boczarska-Jedynak M., Opala G., Krygowska-Wajs A., Barcikowska M., Younkin S.G., Petersen R.C., Ertekin-Taner N., Uitti R.J., Meschia J.F., Boylan K.B., Boeve B.F., Graff-Radford N.R., Wszolek Z.K., Dickson D.W., Rademakers R., Ross O.A. TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease. Mol. Neurodegener. 2013, 8:19.
2. Jonsson T., Stefansson H., Steinberg S., Jonsdottir I., Jonsson P.V., Snaedal J., Bjornsson S., Huttenlocher J., Levey A.I., Lah J.J., Rujescu D., Hampel H., Giegling I., Andreassen O.A., Engedal K., Ulstein I., Djurovic S., Ibrahim-Verbaas C., Hofman A., Ikram M.A., van Duijn C.M., Thorsteinsdottir U., Kong A., Stefansson K. Variant of TREM2 associated with the risk of Alzheimer's disease. N. Engl. J. Med. 2013, 368:107-116.
3. Lill C.M., Rengmark A., Pihlstrøm L., Fogh I., Shatunov A., Sleiman P.M., Wang L.S., Liu T., Lassen C.F., Meissner E., Alexopoulos P., Calvo A., Chio A., Dizdar N., Faltraco F., Forsgren L., Kirchheiner J., Kurz A., Larsen J.P., Liebsch M., Linder J., Morrison K.E., Nissbrandt H., Otto M., Pahnke J., Partch A., Restagno G., Rujescu D., Schnack C., Shaw C.E., Shaw P.J., Tumani H., Tysnes O.B., Valladares O., Silani V., van den Berg L.H., van Rheenen W., Veldink J.H., Lindenberger U., Steinhagen-Thiessen E., SLAGEN Consortium, Teipel S., Perneczky R., Hakonarson H., Hampel H., von Arnim C.A., Olsen J.H., Van Deerlin V.M., Al-Chalabi A., Toft M., Ritz B., Bertram L. The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease. Alzheimers Dement. 2015, pii: S1552-5260(15) 00122-3.
4. Benitez B.A., Cruchaga C. United States-Spain Parkinson's Disease Research G. TREM2 and neurodegenerative disease. N. Engl. J. Med. 2013, 369:1567-1568.